Article Figures & Data
Tables
- Table 1
- The general demographic characteristics of the participants and medical history.
Variables n % Gender Male 66 10.9 Female 538 89.1 Age groups 12-15 253 41.9 16-17 351 58.1 Nationality Saudi 455 75.3 Non- Saudi 149 24.7 Occupation Student 596 98.6 Not student 8 1.4 Health status Good health 558 92.4 Health problem 31 5.1 Chronic disease 15 2.5 Diagnosed with COVID-19 prior to receiving the first dose of the COVID-19 vaccine 110 18.2 Not diagnosed with COVID-19 prior to receiving the first dose of the COVID-19 vaccine 494 81.8 Smoker/former smoker 8 1.3 Non-smoker 596 98.7 Receiving antimicrobial 9 1.5 Not receiving antimicrobial 595 98.5 - Table 2
- Participants who experienced side effects, as well as the amount of doses administered (N=604).
Side effect First dose n (%) Second dose n (%) Type of vaccine BNT162b2 (Pfizer) 593 (98.2) 556 (92.1) Moderna 11 (1.8) 39 (6.5) Missing data 0 9 (1.5) Side effects after the dose Feeling tired and headache 354 (58.6) 388 (64.2) Pain on the injection site 514 (85.1) 482 (79.8) Muscle and joint pain and feeling unwell 201 (33.3) 235 (38.9) High temperature and shivering in the body 167 (27.6) 232 (38.4) Dizziness 129 (21.4) 164 (27.2) Vomiting 24 (4.0) 39 (6.5) Breathing congestion 26 (4.3) 40 (6.6) Menstrual disorder 123 (20.4) 106 (17.5) Skin itching or rash 26 (4.3) 24 (4.0) No sides effect 35 (5.7) 4 (1.0) Missing data 0 9 (1.5) Side effects were most prominent on the First day 281 (46.5) 320 (53) Second day 292 (48.3) 253 (41.9) Third day 10 (1.7) 12 (2) Other 21 (3.5) 19 (3.1) The severity of the side effects Mild 247 (40.9) 186 (30.8) Moderate 303 (50.2) 264 (43.7) Severe 54 (8.9) 136 (22.5) Missing data 0 18 (3.0) For how long did the side effect last after vaccination: 1–2 days 346 (57.3) 348 (57.6) 3 days 209 (34.6) 176 (29.1) 4 or more 49 (8.1) 60 (9.9) Missing data 0 20 (3.3) Medication usage Take any medication to reduce the severity of the side effects 357 (59.1) 381 (63.1) Not taking any medication to reduce the severity of the side effects 247 (40.9) 211 (34.9) Missing data 0 12 (2.0) Side Effect Variables B P-value Odds ratio 95% CI Lower 95% CI Upper Muscle and joint pain Gender -0.45 0.14 0.64 0.36 1.15 Presence of chronic disease 0.89 0.01* 2.45 1.24 4.83 Dizziness Gender -1.35 0.01* .26 0.10 0.66 Presence of chronic disease 0.87 0.02* 2.39 1.16 4.94 Breathing congestion Gender -1.26 0.22 0.28 0.04 2.16 Presence of chronic disease 1.50 0.01* 4.46 1.56 12.73 Menstrual disorder Gender NA NA NA NA NA Presence of chronic disease 0.87 0.03* 2.38 1.12 5.10 Assessment is based on patients with chronic disease compared to patients without chronic disease. Gender assessment is males compared to females. *Significant, CI: confidence interval, B: coefficients, NA: not applicable
Side effect Variables B P-value Odds Ratio 95% CI Lower 95% CI Upper Feeling tired and headache Gender 0.58 0.06 1.78 0.98 3.24 Presence of chronic disease -0.71 0.04* 0.49 0.25 0.97 Breathing congestion Gender 0.33 0.49 1.39 0.55 3.49 Presence of chronic disease 1.33 0.00* 3.77 1.53 9.28 Assessment is based on patients with chronic disease compared to patients without chronic disease. Gender assessment is males compared to females. *Significant, CI: confidence interval, B: coefficients